Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trialPeter B. Gilbert, David C. Montefiori, Adrian B. McDermott et al.|Science|2022Cited by 1.2k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender WomenRaphael J. Landovitz, Sheldon D. Fields, Trần Việt Hà et al.|New England Journal of Medicine|2021Cited by 847
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trialNadine Rouphael, Wendy Nesheim, Michele Paine et al.|The Lancet|2017Cited by 423
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy TrialPeter B. Gilbert, Richard A. Koup, David C. Montefiori et al.|medRxiv|2021Cited by 138
Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine TrialsAlfredo J Mena Lora, Catherine Orrel, Jessica E. Long et al.|JAMA Network Open|2023Cited by 38